| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2,777,777 | 42% | $9.00 | +$24,999,993 |
| Sells | 5 | -3,814,642 | 58% | $36.59 | -$139,578,705 |
| Net | -4 | -1,036,865 | -16% | -$114,578,712 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | Director | $798,960,735 | -$102,400,007 | -11% | 22 Jan 2026 |
| Andrew R. Robbins | President and CEO, Director | $25,938,493 | 17 Dec 2025 | ||
| Cole Pinnow | Chief Commercial Officer | $8,546,842 | 17 Dec 2025 | ||
| John Edward Robinson | Chief Scientific Officer | $5,423,677 | -$3,486,600 | -39% | 26 Dec 2025 |
| Jessica Sachs | Chief Medical Officer | $5,183,400 | -$3,198,245 | -38% | 26 Dec 2025 |
| John L. Green | Chief Financial Officer | $5,099,339 | -$2,978,360 | -37% | 26 Dec 2025 |
| Evan D. Kearns | Chief Legal Officer | $4,233,702 | -$2,515,500 | -37% | 26 Dec 2025 |
| Todd Shegog | Director | 04 Jun 2025 | |||
| Arlene Morris | Director | 04 Jun 2025 | |||
| CHRISTOPHER W. CAIN | Director | 04 Jun 2025 | |||
| Peter Evan Harwin | Director | 04 Jun 2025 | |||
| Matthew Ros | Director | 04 Jun 2025 | |||
| Karen Jean Ferrante | Director | 01 Jan 2026 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|